$22.88
$-0.52 (-2.22%)
End-of-day quote: 05/17/2024
NasdaqGM:VCYT
Veracyte Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$361.05M | $296.54M | $219.51M | $117.48M | $120.37M | $92.01M | $71.95M | $65.09M | $49.50M | $38.19M | $21.88M | |
| GM % | Gross Margin % |
|
68.73% | 65.74% | 66.11% | 65.64% | 69.66% | 64.05% | 43.60% | 60.88% | 56.57% | 56.52% | 42.39% | |
| OM | Operating Margin |
|
-4.97% | -12.69% | -24.63% | -27.91% | -12.57% | -24.16% | -36.88% | -44.25% | -67.60% | -71.50% | -105.89% | |
| EPS | Earnings Per Share |
|
$0.00 | $-1.02 | $-0.51 | $-1.11 | $-0.66 | $-0.27 | $-0.62 | $-0.91 | $-1.09 | $-1.30 | $-1.36 | $-6.15 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
73.26m | 71.96m | 71.12m | 58.2m | 49.63m | 40.86m | 34.21m | 33.76m | 27.69m | 22.52m | 21.14m | |
| OCF | Operating Cash Flow |
|
$44.22M | $7.54M | $-31.62M | $-9.71M | $-3.23M | $-13.52M | $-23.92M | $-27.98M | $-26.97M | $-27.63M | $-19.16M | |
| FCF | Free Cash Flow |
|
$21.20M | $-1.01M | $-37.00M | $-12.55M | $-5.99M | $-15.40M | $-25.67M | $-32.19M | $-33.13M | $-29.66M | $-20.49M | |
| FCFS | Free Cash Flow Per Share |
|
$0.47 | $-0.01 | $-0.54 | $-0.24 | $-0.13 | $-0.42 | $-0.76 | $-1.12 | $-1.27 | $-1.37 | $-4.93 |
